Skip to main content

Closed

ALLO: Allogene Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

26thpctl

Volume

0.67×avg

Market Cap

648.89MUSD

P/E Ratio

-2.6TTM

Div Yield

-ann

Allogene Therapeutics, Inc.

ALLONASDAQ Global Select·USD·Closed

Allogene Therapeutics, Inc.

ALLONASDAQ·USD·Closed

$1.88

−4.57%

$1.88

−$0.09 (4.57%)

52W Range

26thpctl

Volume

0.67×avg

Mkt Cap

648.89MUSD

P/E

-2.6TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings